Working... Menu
Trial record 56 of 57 for:    Romidepsin | Phase 2

Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV Infection (HIVACAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03619278
Recruitment Status : Not yet recruiting
First Posted : August 7, 2018
Last Update Posted : February 21, 2019
IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer
Felipe García - Investigator Coordinator
Information provided by (Responsible Party):
David Garcia Cinca, Hospital Clinic of Barcelona

No Study Results Posted on for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : July 15, 2020
  Estimated Study Completion Date : July 15, 2020